The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Lymphoepithelial Kazal-type related inhibitor (LEKTI) is a multidomain serine protease inhibitor which plays a central role in skin permeability barrier and allergy. Loss-of-function mutations in the LEKTI encoding gene SPINK5 cause Netherton syndrome, a rare and severe genetic skin disease with a profound skin barrier defect and atopic manifestations. Several studies also reported genetic association between the multifactorial disease atopic dermatitis (AD) and a frequent and non-conservative LEKTI variant, E420K, in different populations. Here, we provide evidence that the 420K variant impacts on LEKTI function by increasing the likelihood of furin-dependent LEKTI precursor cleavage within the linker region D6-D7. This results in the reversal of the cleavage priorities for LEKTI proteolytic activation and prevents the formation of the LEKTI fragment D6D9 known to display the strongest inhibitory activity against kallikrein (KLK) 5-mediated desmoglein-1 (DSG1) degradation. Using in situ and gel zymographies, we show that the modification of the subtle balance in LEKTI inhibitory fragments leads to enhanced KLK5, KLK7 and elastase-2 (ELA-2) activities in 420KK epidermis. By immunohistochemistry and western blot analyses, we found that increased epidermal protease activity correlates with reduced DSG1 protein expression and accelerated profilaggrin proteolysis. All changes determined by the presence of residue 420K within the LEKTI sequence likely contribute to defective skin barrier permeability. Remarkably, LEKTI 420KK epidermis displays an increased expression of the proallergic cytokine thymic stromal lymphopoietin (TSLP). This is the first functional evidence supporting association studies which identified the 420K LEKTI variant as a predisposing factor to AD, in combination with other genetic and environmental factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Briot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., & Hovnanian, A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082242 · Cited by 504 · cited 5×
“As we have learnt from NS, unrestrained KLKs activity and epidermal barrier defects secondary to LEKTI deficiency induce the priming of a cutaneous allergic inflammation (22,23).”
BackgroundInfluentialSelf-citationAssociation of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China
Zhao, L. P., Di, Z., Zhang, L., Wang, L., Ma, L., Lv, Y., Hong, Y., Wei, H., Chen, H. D., & Gao, X. H. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04120.x · Cited by 66 · cited 1×
“In particular, since the LEKTI variant 420K identified by several studies as an AD risk factor (25,27,28,30,31) locates in linker 6 near the physiological furin-dependent R425 cleavage site, we theorized that this polymorphic variant could alter LEKTI proprotein activation.”
Background
Cited by
Genetic and epigenetic studies of atopic dermatitis
Bin, L., & Leung, D. Y. M. (2016) · Allergy, Asthma & Clinical Immunology · doi:10.1186/s13223-016-0158-5 · Cited by 242
“These changes all contribute to AD pathogenesis [102, 103].”
BackgroundExacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber
Werfel, T., Heratizadeh, A., Niebuhr, M., Kapp, A., Roesner, L. M., Karch, A., Erpenbeck, V. J., Lösche, C., Jung, T., Krug, N., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.015 · Cited by 171
The Genetics and Epigenetics of Atopic Dermatitis—Filaggrin and Other Polymorphisms
Liang, Y., Chang, C., & Lu, Q. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8508-5 · Cited by 166
“Loss-of-function mutations in SPINK5 might result in excessive KLKs activity which degrades lipid-processing enzymes and corneodesmosome constituent proteins, and then provokes permeability barrier defects [41, 47].”
BackgroundInfluentialGenetics of allergy and allergic sensitization: common variants, rare mutations
Bønnelykke, K., Sparks, R., Waage, J., & Milner, J. D. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.08.002 · Cited by 73
“The SPINK5 E420K variant has been implicated in atopic dermatitis in patients without NS [64].”
Fernando, I. P. S., Dias, M. K. H. M., Madusanka, D. M. D., Han, E. J., Kim, M. J., Heo, S.-J., Lee, K., Cheong, S. H., & Ahn, G. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.115 · Cited by 48
Metadata
- Authors
- Fortugno, P., Furio, L., Teson, M., Berretti, M., El Hachem, M., Zambruno, G., Hovnanian, A., & D'Alessio, M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-23
- Volume
- 21
- Issue
- 19
- Pages
- 4187-4200
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2148623819
- Cited by
- 97
- References
- 4
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis. https://app.cochat.ai/papers/10.1093/hmg/dds243
- The paper
- Fortugno, P., Furio, L., Teson, M., Berretti, M., El Hachem, M., Zambruno, G., Hovnanian, A., & D'Alessio, M. (2012). The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis. Human Molecular Genetics. https://doi.org/10.1093/hmg/dds243
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.